Jim Simons A Tyr Pharma Inc Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,149,175 shares of LIFE stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,149,175

Previous 1,293,814 11.18%

Holding current value

$2.14 Million

Previous $2.02 Million 5.9%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.51 - $2.24 $218,404 - $323,991	-144,639 Reduced 11.18%	1,149,175 $2.14 Million
Q2 2024 Aug 09, 2024	BUY	$0.0 - $2.07 $0 - $43,385	20,959 Added 1.65%	1,293,814 $2.02 Million
Q1 2024 May 13, 2024	BUY	$1.42 - $2.02 $560,733 - $797,663	394,883 Added 44.98%	1,272,855 $2.48 Million
Q4 2023 Feb 13, 2024	BUY	$1.11 - $1.51 $412,896 - $561,688	371,979 Added 73.51%	877,972 $1.24 Million
Q3 2023 Nov 14, 2023	SELL	$1.55 - $2.23 $31,561 - $45,407	-20,362 Reduced 3.87%	505,993 $799,000
Q2 2023 Aug 11, 2023	BUY	$1.72 - $2.57 $634,164 - $947,558	368,700 Added 233.87%	526,355 $1.14 Million
Q1 2023 May 12, 2023	SELL	$1.88 - $2.5 $15,831 - $21,052	-8,421 Reduced 5.07%	157,655 $331,000
Q4 2022 Feb 13, 2023	SELL	$2.02 - $2.49 $43,326 - $53,408	-21,449 Reduced 11.44%	166,076 $364,000
Q3 2022 Nov 14, 2022	BUY	$2.79 - $4.15 $102,393 - $152,305	36,700 Added 24.33%	187,525 $563,000
Q2 2022 Aug 12, 2022	BUY	$2.63 - $5.61 $105,121 - $224,231	39,970 Added 36.06%	150,825 $427,000
Q1 2022 May 13, 2022	SELL	$4.75 - $7.54 $77,425 - $122,902	-16,300 Reduced 12.82%	110,855 $593,000
Q4 2021 Feb 11, 2022	SELL	$7.29 - $9.5 $382,725 - $498,750	-52,500 Reduced 29.22%	127,155 $950,000
Q3 2021 Nov 12, 2021	BUY	$4.22 - $12.48 $14,348 - $42,432	3,400 Added 1.93%	179,655 $1.63 Million
Q2 2021 Aug 13, 2021	SELL	$3.62 - $4.88 $237,852 - $320,640	-65,705 Reduced 27.16%	176,255 $860,000
Q1 2021 May 13, 2021	SELL	$3.53 - $8.06 $272,410 - $621,990	-77,170 Reduced 24.18%	241,960 $1.08 Million
Q4 2020 Feb 10, 2021	SELL	$3.07 - $4.66 $274,151 - $416,138	-89,300 Reduced 21.86%	319,130 $1.24 Million
Q3 2020 Nov 13, 2020	BUY	$3.23 - $5.39 $137,598 - $229,614	42,600 Added 11.64%	408,430 $1.32 Million
Q2 2020 Aug 13, 2020	BUY	$2.55 - $4.58 $399,916 - $718,281	156,830 Added 75.04%	365,830 $1.62 Million
Q1 2020 May 14, 2020	BUY	$2.17 - $7.06 $19,703 - $64,104	9,080 Added 4.54%	209,000 $585,000
Q4 2019 Feb 13, 2020	BUY	$3.03 - $4.83 $19,089 - $30,429	6,300 Added 3.25%	199,920 $834,000
Q3 2019 Nov 13, 2019	BUY	$2.8 - $5.46 $542,136 - $1.06 Million	193,620 New	193,620 $678,000

Others Institutions Holding LIFE

# of Institutions

Shares Held

37.1M

Call Options Held

30.2K

Put Options Held

3.1K

View Full List

About aTYR PHARMA INC

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

More about LIFE

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account